Santopaolo, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 382
EU - Europa 325
AS - Asia 150
AF - Africa 9
Totale 866
Nazione #
US - Stati Uniti d'America 381
IT - Italia 128
SE - Svezia 66
SG - Singapore 60
IE - Irlanda 59
ID - Indonesia 34
CN - Cina 31
DE - Germania 15
RU - Federazione Russa 13
FI - Finlandia 11
CZ - Repubblica Ceca 9
FR - Francia 9
IN - India 9
HK - Hong Kong 6
TZ - Tanzania 5
CI - Costa d'Avorio 4
GB - Regno Unito 4
BY - Bielorussia 3
IR - Iran 2
MY - Malesia 2
RO - Romania 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
DK - Danimarca 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
PA - Panama 1
PT - Portogallo 1
Totale 866
Città #
Chandler 107
Dublin 59
Ashburn 58
Singapore 44
Milan 42
Jakarta 33
New York 27
Rome 25
Boardman 18
Moscow 13
Princeton 11
Boston 10
Arezzo 8
Los Angeles 8
Pune 8
Beijing 7
Marseille 7
Helsinki 6
Hong Kong 6
Bremen 5
Brno 5
Lappeenranta 5
Quanzhou 5
Abidjan 4
Castel di Sangro 4
Washington 4
Bologna 3
Brdo 3
Cernusco sul Naviglio 3
Coreno Ausonio 3
Dar es Salaam 3
Seattle 3
Cluj-Napoca 2
Forlì 2
Frankfurt am Main 2
Hounslow 2
Kuala Lumpur 2
Leawood 2
Munich 2
Paris 2
Vigevano 2
Vitebsk 2
Brussels 1
Castrolibero 1
Copenhagen 1
Credaro 1
Douglas 1
Dubai 1
Edinburgh 1
Istanbul 1
La Veta 1
Miami 1
Naples 1
Nuremberg 1
Prague 1
Riccione 1
Roggiano Gravina 1
Sacramento 1
Sao Joao da Talha 1
Seoul 1
Tampa 1
Vientiane 1
Totale 587
Nome #
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 69
Benign liver lesions 2022: Guideline for clinical practice of Associazione Italiana Studio del Fegato (AISF), Società Italiana di Radiologia Medica e Interventistica (SIRM), Società Italiana di Chirurgia (SIC), Società Italiana di Ultrasonologia in Medicina e Biologia (SIUMB), Associazione Italiana di Chirurgia Epatobilio-Pancreatica (AICEP), Società Italiana Trapianti d'Organo (SITO), Società Italiana di Anatomia Patologica e Citologia Diagnostica (SIAPEC-IAP) – Part II - Solid lesions 48
Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project 48
Advances in pharmacotherapeutics for hepatocellular carcinoma 44
Durvalumab: an investigational agent for unresectable hepatocellular carcinoma 44
Bariatric surgery and liver disease: General considerations and role of the gut–liver axis 41
Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection 39
Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients 38
Assessing Baveno VI criteria with liver stiffness measured using a new point-shear wave elastography technique (BAVElastPQ study) 38
Fecal microbiota transplantation in patients with hbv infection or other chronic liver diseases: Update on current knowledge and future perspectives 34
Letter: liver involvement and mortality in COVID-19 patients – authors' reply 34
Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients 33
SIRT in 2025 24
Cellular therapies in liver and pancreatic diseases 23
Benign liver lesions 2022: Guideline for clinical practice of Associazione Italiana Studio del Fegato (AISF), Società Italiana di Radiologia Medica e Interventistica (SIRM), Società Italiana di Chirurgia (SIC), Società Italiana di Ultrasonologia in Medicina e Biologia (SIUMB), Associazione Italiana di Chirurgia Epatobilio-Pancreatica (AICEP), Società Italiana Trapianti d'Organo (SITO), Società Italiana di Anatomia Patologica e Citologia Diagnostica (SIAPEC-IAP) – Part I – Cystic lesions 22
Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies 21
Direct portal pressure gradient measurement in patients with porto-sinusoidal vascular disease 21
Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties 21
Low ADAMTS-13/VWF ratio and altered gut-liver axis predict complications of advanced chronic liver disease: a pilot study 21
Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment 20
Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals 20
Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection 20
ADAMTS-13/von Willebrand factor ratio: A prognostic biomarker for portal vein thrombosis in compensated cirrhosis. A prospective observational study 20
Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis 18
The Gut-Vascular Barrier as a New Protagonist in Intestinal and Extraintestinal Diseases 17
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors 17
From coagulation imbalance to prediction of advanced chronic liver disease decompensation: the wind of change? 16
Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives 16
Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows 14
The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence 13
Endotoxemia and Gastrointestinal Cancers: Insight into the Mechanisms Underlying a Dangerous Relationship 13
Endotoxemia and Gastrointestinal Cancers: Insight into the Mechanisms Underlying a Dangerous Relationship 12
Management of Portal Hypertension in Patients with Hepatocellular Carcinoma on Systemic Treatment: Current Evidence and Future Perspectives 7
Late HBV reactivation after hematopoietic stem cell transplantation, despite long-term prophylaxis 6
Exploring the link: Porto-sinusoidal vascular disorder and inflammatory bowel disease - A comprehensive narrative review 4
Type 2 Diabetes Mellitus and Liver Disease: Across the Gut-Liver Axis from Fibrosis to Cancer 3
Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications 3
Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis 2
Totale 904
Categoria #
all - tutte 7.209
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.209


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202245 0 0 0 0 0 0 0 0 3 1 18 23
2022/2023327 38 36 16 41 14 36 13 37 39 6 17 34
2023/2024405 19 91 19 23 34 69 32 8 5 23 32 50
2024/2025127 17 17 88 5 0 0 0 0 0 0 0 0
Totale 904